If the KI is defined by the free energy of binding to P-glycoprotein, which kinetic parameters define the IC50 for the Madin-Darby canine kidney II cell line overexpressing human multidrug resistance 1 confluent cell monolayer?
about
ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humansFitting the elementary rate constants of the P-gp transporter network in the hMDR1-MDCK confluent cell monolayer using a particle swarm algorithmPgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat dataTransport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp.A novel application of t-statistics to objectively assess the quality of IC50 fits for P-glycoprotein and other transportersVariability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria.Interaction of HM30181 with P-glycoprotein at the murine blood-brain barrier assessed with positron emission tomographyComputational approaches to analyse and predict small molecule transport and distribution at cellular and subcellular levelsIn vitro methods to support transporter evaluation in drug discovery and development.Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter.The importance of villous physiology and morphology in mechanistic physiologically-based pharmacokinetic models.
P2860
Q27022933-07AF6485-1458-4069-9AC3-FF972FC64C5EQ28743796-36FBB6D4-E4DD-4795-A5EF-B6BEF121F389Q34100185-682B52B2-C710-4CD7-99EE-7A54FDA260A2Q34970234-2D35A825-53E0-40E8-B296-2AF48B0F273CQ35563235-B19AA7E2-BD1A-47D7-9D6D-E0837E379DB8Q36935254-1CE2EF8E-393C-4BF7-B1F2-8B440FA6A6E2Q36949407-CB5433CD-305B-4A97-9CF6-0D6FA9AFB3FAQ37626169-DA67F2B1-0044-415A-982B-ED5F4072D0AFQ38099194-5110AB89-78EB-440F-A0E2-E7BF4620E04AQ39133110-51B3F7BA-80A7-4440-9073-A069095A2CF6Q47976571-FC932DFF-7CFA-4A63-9DE9-7A6BE14A257D
P2860
If the KI is defined by the free energy of binding to P-glycoprotein, which kinetic parameters define the IC50 for the Madin-Darby canine kidney II cell line overexpressing human multidrug resistance 1 confluent cell monolayer?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
If the KI is defined by the fr ...... ce 1 confluent cell monolayer?
@en
If the KI is defined by the fr ...... ce 1 confluent cell monolayer?
@nl
type
label
If the KI is defined by the fr ...... ce 1 confluent cell monolayer?
@en
If the KI is defined by the fr ...... ce 1 confluent cell monolayer?
@nl
prefLabel
If the KI is defined by the fr ...... ce 1 confluent cell monolayer?
@en
If the KI is defined by the fr ...... ce 1 confluent cell monolayer?
@nl
P2093
P921
P356
P1476
If the KI is defined by the fr ...... ce 1 confluent cell monolayer?
@en
P2093
Andrew Ayrton
Annie Albin Lumen
Harma Ellens
Poulomi Acharya
P304
P356
10.1124/DMD.109.029843
P577
2009-11-04T00:00:00Z